ALT earnings: a positive outcome, +8.6%

On May 12, 2022, Altimmune, Inc. reached its earnings. The result was a positive outcome, and the stock moved +8.6% in the window around the event. It had already run -24.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.